⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HROW News
Harrow, Inc. Common Stock
Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
globenewswire.com
HROW
HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law Violations
globenewswire.com
HROW
Form 8-K
sec.gov
HROW
Harrow Announces First Quarter 2026 Financial Results
globenewswire.com
HROW
Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026
globenewswire.com
HROW
Harrow Announces the Issuance of J-Code for IOPIDINE® 1%
globenewswire.com
HROW
LogiCare3PL Selected as Distribution Partner by Harrow
prnewswire.com
HROW
Form 8-K
sec.gov
HROW